PMID: 1736326Jan 1, 1992Paper

Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes--the Radiotherapy Cooperative Group

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
T D NguyenG Chaplain

Abstract

Between 1971 and 1989, 59 patients received external radiation therapy with a curative intent. There were 25 females and 34 males, ranging in age from 19 to 87. No patients had distant metastasis at the onset of treatment. The majority of patients had a total thyroidectomy (55/59), generally combined with neck dissection. Residual tumour was left in 11 cases, and 44 patients had positive cervical nodes. Using megavoltage radiotherapy, the whole neck and the upper mediastinum area were most often irradiated through a large anterior Y-shaped field without laryngeal shielding. The mean dose to the tumoral bed was 54 Gy. Dysphagia was observed in 32 patients (11, 17 and 5 scores were grade 1, 2 and 3, respectively). Dyspnea occurred in five cases and in two of these cases, it was considered to be severe. Local recurrences were noted in 18 (30%) patients, most of them occurring within the fields of irradiation. Parameters such as age, sex, total dose, irradiated volumes or cervical node enlargement did not modify the local control rate. The same conclusions can be drawn for distant failures. Thirty five patients are still alive and among them, 24 have no evidence of disease. The average length of survival is 70.5 months and is short...Continue Reading

References

Oct 1, 1988·The Journal of Clinical Endocrinology and Metabolism·N A SamaanR C Hickey
Oct 1, 1988·Minnesota Medicine·R L TelanderJ A van Heerden
Feb 1, 1983·International Journal of Radiation Oncology, Biology, Physics·P RougierM Tubiana
Apr 1, 1980·American Journal of Surgery·R L RossiJ Werber

❮ Previous
Next ❯

Citations

Jun 12, 2002·Current Treatment Options in Oncology·E Kebebew, O H Clark
Aug 29, 2003·Current Treatment Options in Oncology·Jeffrey F Moley
Jun 22, 2005·Current Treatment Options in Oncology·Amber Traugott, Jeffrey F Moley
Jul 1, 1997·The American Journal of Medicine·H M HeshmatiG W Sizemore
Aug 21, 2002·Thyroid : Official Journal of the American Thyroid Association·N FershtC Harmer
Aug 1, 1996·Thyroid : Official Journal of the American Thyroid Association·J BrierleyT Panzarella
May 28, 2009·Thyroid : Official Journal of the American Thyroid Association·UNKNOWN American Thyroid Association Guidelines Task ForceSamuel A Wells
Jan 7, 2004·The American Journal of Surgical Pathology·Hina A SheikhJennifer L Hunt
Nov 8, 2012·Future Oncology·Concetto RegalbutoVincenzo Pezzino
May 16, 2014·Oral Oncology·Joseph K SalamaJonathan J Beitler
May 27, 2008·Endocrinology and Metabolism Clinics of North America·James D Brierley, Richard W Tsang
Jun 6, 2007·Hematology/oncology Clinics of North America·Ana O Hoff, Paulo M Hoff
Mar 1, 1996·Endocrinology and Metabolism Clinics of North America·J D Brierley, R W Tsang
Feb 11, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jun-Etsu MizoeUNKNOWN Organizing Committee for the Working Group for Head Neck Cancer
Jul 12, 2016·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·F CompagnonP Graff
Feb 19, 2005·Journal of Surgical Oncology·Frank J Quayle, Jeffrey F Moley
Jun 25, 2010·Advances in Anatomic Pathology·Peter M Sadow, Jennifer L Hunt
Jan 1, 1997·Cancer Control : Journal of the Moffitt Cancer Center·M G Franz
Jul 6, 2004·Current Treatment Options in Oncology·Michael E Gertner, Electron Kebebew
Jun 1, 2000·Cancer Control : Journal of the Moffitt Cancer Center·G W Randolph, D Maniar
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D Giuffrida, H Gharib
Dec 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K M FifeC L Harmer
Jan 6, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·P C WilsonJ D Brierley
Jan 8, 2008·Surgical Oncology Clinics of North America·Jon F StrasserChris Koprowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
K M FifeC L Harmer
American Journal of Surgery
W J SimpsonR A Mustard
© 2021 Meta ULC. All rights reserved